Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Nu Skin Enterprises

NYSE:NUS
Snowflake Description

6 star dividend payer and undervalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NUS
NYSE
$1B
Market Cap
  1. Home
  2. US
  3. Household
Company description

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. The last earnings update was 52 days ago. More info.


Add to Portfolio Compare Print
  • Nu Skin Enterprises has significant price volatility in the past 3 months.
NUS Share Price and Events
7 Day Returns
1%
NYSE:NUS
-6.1%
US Personal Products
-2.8%
US Market
1 Year Returns
-56.5%
NYSE:NUS
-19.5%
US Personal Products
-15.9%
US Market
NUS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Nu Skin Enterprises (NUS) 1% -11.9% -44.9% -56.5% -59% -63.7%
US Personal Products -6.1% -21.8% -28.8% -19.5% 14.3% 1.7%
US Market -2.8% -18.8% -24% -15.9% 2.8% 13.3%
1 Year Return vs Industry and Market
  • NUS underperformed the Personal Products industry which returned -19.5% over the past year.
  • NUS underperformed the Market in United States of America which returned -15.9% over the past year.
Price Volatility
NUS
Industry
5yr Volatility vs Market

NUS Value

 Is Nu Skin Enterprises undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Nu Skin Enterprises to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Nu Skin Enterprises.

NYSE:NUS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.4%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:NUS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.59
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.594 (1 + (1- 21%) (41.38%))
0.858
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.86
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (0.858 * 5.44%)
6.41%

Discounted Cash Flow Calculation for NYSE:NUS using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Nu Skin Enterprises is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NYSE:NUS DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.41%)
2020 76.88 Analyst x3 72.25
2021 95.00 Analyst x3 83.90
2022 156.34 Analyst x2 129.77
2023 190.15 Analyst x1 148.32
2024 215.06 Est @ 13.1% 157.65
2025 235.90 Est @ 9.69% 162.51
2026 253.13 Est @ 7.31% 163.88
2027 267.40 Est @ 5.64% 162.70
2028 279.34 Est @ 4.47% 159.73
2029 289.53 Est @ 3.65% 155.59
Present value of next 10 years cash flows $1,396.00
NYSE:NUS DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $289.53 × (1 + 1.74%) ÷ (6.41% – 1.74%)
$6,311.04
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $6,311.04 ÷ (1 + 6.41%)10
$3,391.38
NYSE:NUS Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $1,396.00 + $3,391.38
$4,787.38
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $4,787.38 / 55.55
$86.19
NYSE:NUS Discount to Share Price
Calculation Result
Value per share (USD) From above. $86.19
Current discount Discount to share price of $22.06
= -1 x ($22.06 - $86.19) / $86.19
74.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Nu Skin Enterprises is available for.
Intrinsic value
>50%
Share price is $22.06 vs Future cash flow value of $86.19
Current Discount Checks
For Nu Skin Enterprises to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Nu Skin Enterprises's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Nu Skin Enterprises's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Nu Skin Enterprises's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Nu Skin Enterprises's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:NUS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $3.13
NYSE:NUS Share Price ** NYSE (2020-04-03) in USD $22.06
United States of America Personal Products Industry PE Ratio Median Figure of 18 Publicly-Listed Personal Products Companies 10.69x
United States of America Market PE Ratio Median Figure of 2,947 Publicly-Listed Companies 12.21x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Nu Skin Enterprises.

NYSE:NUS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:NUS Share Price ÷ EPS (both in USD)

= 22.06 ÷ 3.13

7.06x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nu Skin Enterprises is good value based on earnings compared to the US Personal Products industry average.
  • Nu Skin Enterprises is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Nu Skin Enterprises's expected growth come at a high price?
Raw Data
NYSE:NUS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 7.06x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
-8.4%per year
United States of America Personal Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Personal Products Companies 1.58x
United States of America Market PEG Ratio Median Figure of 2,010 Publicly-Listed Companies 0.88x

*Line of best fit is calculated by linear regression .

NYSE:NUS PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 7.06x ÷ -8.4%

-0.84x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nu Skin Enterprises earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Nu Skin Enterprises's assets?
Raw Data
NYSE:NUS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $15.74
NYSE:NUS Share Price * NYSE (2020-04-03) in USD $22.06
United States of America Personal Products Industry PB Ratio Median Figure of 43 Publicly-Listed Personal Products Companies 1.73x
United States of America Market PB Ratio Median Figure of 5,146 Publicly-Listed Companies 1.2x
NYSE:NUS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:NUS Share Price ÷ Book Value per Share (both in USD)

= 22.06 ÷ 15.74

1.4x

* Primary Listing of Nu Skin Enterprises.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nu Skin Enterprises is good value based on assets compared to the US Personal Products industry average.
X
Value checks
We assess Nu Skin Enterprises's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Nu Skin Enterprises has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NUS Future Performance

 How is Nu Skin Enterprises expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-8.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Nu Skin Enterprises expected to grow at an attractive rate?
  • Nu Skin Enterprises's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 1.7%.
Growth vs Market Checks
  • Nu Skin Enterprises's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
  • Nu Skin Enterprises's revenues are expected to decrease over the next 1-3 years, this is below the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:NUS Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:NUS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts -8.4%
NYSE:NUS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts -4.2%
United States of America Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 19%
United States of America Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 5.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:NUS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:NUS Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31
2022-12-31 2,094 198 1
2021-12-31 2,226 182 149 5
2020-12-31 2,121 166 120 5
2020-04-05
NYSE:NUS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 2,420 178 174
2019-09-30 2,520 217 116
2019-06-30 2,606 225 125
2019-03-31 2,686 196 129
2018-12-31 2,679 203 122
2018-09-30 2,662 261 158
2018-06-30 2,550 270 146
2018-03-31 2,396 280 137
2017-12-31 2,279 303 129
2017-09-30 2,144 246 149
2017-06-30 2,185 223 165
2017-03-31 2,235 299 167

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Nu Skin Enterprises's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Nu Skin Enterprises's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:NUS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Nu Skin Enterprises Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:NUS Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 2.72 3.10 2.29 4.00
2020-12-31 2.17 2.33 1.86 4.00
2020-04-05
NYSE:NUS Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 3.13
2019-09-30 2.08
2019-06-30 2.25
2019-03-31 2.33
2018-12-31 2.21
2018-09-30 2.90
2018-06-30 2.72
2018-03-31 2.59
2017-12-31 2.45
2017-09-30 2.82
2017-06-30 3.06
2017-03-31 3.06

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Nu Skin Enterprises is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Nu Skin Enterprises's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Nu Skin Enterprises has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NUS Past Performance

  How has Nu Skin Enterprises performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Nu Skin Enterprises's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Nu Skin Enterprises's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Nu Skin Enterprises's 1-year earnings growth exceeds its 5-year average (42.4% vs -3.5%)
  • Nu Skin Enterprises's earnings growth has exceeded the US Personal Products industry average in the past year (42.4% vs 25.5%).
Earnings and Revenue History
Nu Skin Enterprises's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Nu Skin Enterprises Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:NUS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 2,420.42 173.55 1,571.57
2019-09-30 2,520.34 115.68 1,615.77
2019-06-30 2,605.72 124.74 1,673.07
2019-03-31 2,686.41 129.35 1,730.68
2018-12-31 2,679.01 121.89 1,733.32
2018-09-30 2,661.92 157.88 1,719.63
2018-06-30 2,550.31 146.41 1,660.95
2018-03-31 2,396.22 137.49 1,571.92
2017-12-31 2,279.10 129.44 1,502.54
2017-09-30 2,144.23 149.39 1,445.94
2017-06-30 2,184.69 164.59 1,463.36
2017-03-31 2,235.07 167.26 1,491.99
2016-12-31 2,207.80 143.09 1,476.24
2016-09-30 2,248.67 140.74 1,503.26
2016-06-30 2,215.81 100.14 1,483.34
2016-03-31 2,175.55 100.08 1,469.02
2015-12-31 2,247.05 133.05 1,512.84
2015-09-30 2,284.46 143.71 1,535.59
2015-06-30 2,351.95 195.75 1,584.15
2015-03-31 2,441.77 170.60 1,645.28
2014-12-31 2,569.50 189.18 1,738.87
2014-09-30 3,015.67 267.94 2,029.59
2014-06-30 3,285.17 310.53 2,205.23
2014-03-31 3,306.47 365.46 2,211.42
2013-12-31 3,176.72 364.89 2,116.80
2013-09-30 2,671.77 298.85 1,781.17
2013-06-30 2,289.65 242.13 1,538.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Nu Skin Enterprises has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Nu Skin Enterprises used its assets less efficiently than the US Personal Products industry average last year based on Return on Assets.
  • Nu Skin Enterprises's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Nu Skin Enterprises's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Nu Skin Enterprises has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NUS Health

 How is Nu Skin Enterprises's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Nu Skin Enterprises's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Nu Skin Enterprises is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Nu Skin Enterprises's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Nu Skin Enterprises's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Nu Skin Enterprises Company Filings, last reported 3 months ago.

NYSE:NUS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 875.29 361.96 345.25
2019-09-30 845.80 366.72 327.49
2019-06-30 834.95 408.49 368.37
2019-03-31 811.20 401.25 318.33
2018-12-31 781.87 430.46 399.73
2018-09-30 832.13 448.22 401.45
2018-06-30 803.53 468.01 410.23
2018-03-31 799.13 469.93 430.10
2017-12-31 704.60 388.63 439.39
2017-09-30 717.52 418.22 371.75
2017-06-30 699.57 424.59 353.08
2017-03-31 687.59 428.48 347.34
2016-12-31 664.07 416.89 369.21
2016-09-30 854.41 429.63 532.60
2016-06-30 830.24 458.95 556.35
2016-03-31 801.43 263.07 265.06
2015-12-31 825.62 249.59 305.24
2015-09-30 860.52 252.97 316.69
2015-06-30 903.89 252.14 303.93
2015-03-31 923.85 265.10 316.34
2014-12-31 942.44 247.34 301.45
2014-09-30 939.41 188.71 207.17
2014-06-30 891.76 211.45 233.73
2014-03-31 875.56 197.91 303.28
2013-12-31 858.62 181.68 548.21
2013-09-30 742.43 189.17 565.60
2013-06-30 692.09 198.13 411.43
  • Nu Skin Enterprises's level of debt (41.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (26.3% vs 41.4% today).
  • Debt is well covered by operating cash flow (49.2%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 13.9x coverage).
X
Financial health checks
We assess Nu Skin Enterprises's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Nu Skin Enterprises has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NUS Dividends

 What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
6.8%
Current annual income from Nu Skin Enterprises dividends. Estimated to be 6.38% next year.
If you bought $2,000 of Nu Skin Enterprises shares you are expected to receive $136 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Nu Skin Enterprises's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (2.07%).
  • Nu Skin Enterprises's dividend is above the markets top 25% of dividend payers in United States of America (5.82%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:NUS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
United States of America Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1936 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2.1%
United States of America Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:NUS Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31 1.65 2.00
2021-12-31 1.34 4.00
2020-12-31 1.35 4.00
2020-04-05
NYSE:NUS Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2020-02-12 1.500 6.668
2019-11-05 1.480 3.843
2019-08-06 1.480 3.511
2019-04-30 1.480 3.132
2019-02-13 1.480 2.734
2018-11-07 1.460 2.290
2018-08-02 1.460 1.888
2018-04-26 1.460 1.874
2018-02-15 1.460 2.014
2017-11-01 1.440 2.140
2017-08-02 1.440 2.353
2017-05-03 1.440 2.414
2017-02-16 1.440 2.728
2016-11-03 1.420 2.753
2016-08-04 1.420 2.336
2016-04-28 1.420 3.256
2016-02-11 1.420 4.054
2015-10-29 1.400 4.052
2015-08-06 1.400 3.371
2015-05-06 1.400 3.008
2015-02-05 1.400 2.448
2014-11-05 1.380 3.272
2014-08-19 1.380 3.037
2014-05-07 1.380 2.073
2014-03-03 1.380 1.694
2013-10-30 1.200 1.161
2013-08-01 1.200 1.281
2013-05-09 1.200 1.840
2012-12-18 1.200 2.762
2012-10-31 0.800 1.764
2012-08-01 0.800 1.888
2012-05-03 0.800 1.792
2012-02-02 0.800 1.429
2011-10-28 0.800 1.658
2011-07-19 0.640 1.556
2011-05-10 0.540 1.436
2011-02-02 0.540 1.751
2010-10-28 0.500 1.619
2010-08-04 0.500 1.773
2010-05-18 0.500 1.834
2010-02-09 0.500 1.726
2009-11-16 0.460 1.744
2009-08-07 0.460 2.328
2009-06-04 0.460 2.935

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Nu Skin Enterprises's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.5x coverage).
X
Income/ dividend checks
We assess Nu Skin Enterprises's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Nu Skin Enterprises afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Nu Skin Enterprises has a total score of 6/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NUS Management

 What is the CEO of Nu Skin Enterprises's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ritch Wood
COMPENSATION $6,065,610
AGE 53
TENURE AS CEO 3.1 years
CEO Bio

Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to March 7, 2017 and also served as its Principal Accounting Officer and Vice President. Mr. Wood served as Vice President of Finance for Nu Skin Enterprises Inc. from July 2002 to November 2002. He served as Vice President of New Market Development from June 2001 to July 2002 and as the Controller of Pharmanex Division as well as Director of Finance, New Market Development from 1998 to June 2001. He served as Nu Skin Enterprises Inc.’s European Regional Controller from 1995 to 1998 and its Assistant Director of Tax from 1993 to 1995. Prior to Nu Skin Enterprises Inc., he worked for the accounting firm of Grant Thornton LLP. He joined Nu Skin in 1993 and has served in various capacities. He has expertise in accounting, finance, investor relations and management. He has played an important role in managing the growth of Nu Skin business while prioritizing profitability and stockholder value. Mr. Wood is a trustee of the Force for Good Foundation. He has been a Director of Nu Skin Enterprises, Inc. since March 11, 2017. He was named CFO of the Year by Utah Business Magazine in 2010. He is a Certified Public Accountant. He holds a BS and a Master of Accountancy degree from Brigham Young University.

CEO Compensation
  • Ritch's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Ritch's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Nu Skin Enterprises management team in years:

3.1
Average Tenure
55
Average Age
  • The tenure for the Nu Skin Enterprises management team is about average.
Management Team

Steve Lund

TITLE
Executive Chairman of the Board
COMPENSATION
$1M
AGE
66

Ritch Wood

TITLE
CEO & Director
COMPENSATION
$6M
AGE
53
TENURE
3.1 yrs

Ryan Napierski

TITLE
President
COMPENSATION
$3M
AGE
45
TENURE
3.1 yrs

Mark Lawrence

TITLE
Executive VP & CFO
COMPENSATION
$2M
AGE
49
TENURE
3.1 yrs

Joe Chang

TITLE
Executive VP of Product Development & Chief Scientific Officer
COMPENSATION
$2M
AGE
66
TENURE
14.2 yrs

Matt Dorny

TITLE
Executive VP
COMPENSATION
$2M
AGE
55
TENURE
17.3 yrs

Blake Roney

TITLE
COMPENSATION
$622K
AGE
60
TENURE
36.3 yrs

Sandie Tillotson

TITLE
COMPENSATION
$1M
AGE
62
TENURE
24.3 yrs

James Thomas

TITLE
Chief Accounting Officer
AGE
41
TENURE
0.7 yrs

Vince Perfetti

TITLE
Chief Transformation Officer & Senior VP of Technology
TENURE
0.9 yrs
Board of Directors Tenure

Average tenure and age of the Nu Skin Enterprises board of directors in years:

9.1
Average Tenure
66
Average Age
  • The tenure for the Nu Skin Enterprises board of directors is about average.
Board of Directors

Ritch Wood

TITLE
CEO & Director
COMPENSATION
$6M
AGE
53
TENURE
2.9 yrs

Andy Lipman

TITLE
Independent Director
COMPENSATION
$299K
AGE
67
TENURE
20.9 yrs

Steve Lund

TITLE
Executive Chairman of the Board
COMPENSATION
$1M
AGE
66
TENURE
7.9 yrs

Thomas Pisano

TITLE
Independent Director
COMPENSATION
$298K
AGE
74
TENURE
11.8 yrs

Edwina Woodbury

TITLE
Independent Director
COMPENSATION
$298K
AGE
67
TENURE
4.8 yrs

Dan Campbell

TITLE
Lead Independent Director
COMPENSATION
$300K
AGE
64

Tomas Prolla

TITLE
Member of Anti-aging Scientific Advisory Board
TENURE
10.5 yrs

Zoe Draelos

TITLE
Member of the Anti-Aging Scientific Advisory Board
TENURE
10.3 yrs

Simon Shen

TITLE
Independent Director
COMPENSATION
$255K
AGE
39
TENURE
3.8 yrs

Lars Bohlin

TITLE
Member of Anti-Aging Scientific Advisory Board
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Nu Skin Enterprises individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
23. Mar 20 Buy Ritch Wood Individual 20. Mar 20 20. Mar 20 10,000 $20.25 $202,500
X
Management checks
We assess Nu Skin Enterprises's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Nu Skin Enterprises has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NUS News

Simply Wall St News

Does Nu Skin Enterprises, Inc.'s (NYSE:NUS) September Stock Price Reflect Its Future Growth?

NUS is trading at price-to-earnings (PE) ratio of 18.08x, which suggests that Nu Skin Enterprises is undervalued based on its latest annual earnings update compared to the Personal Products average of 21.84x , and overvalued compared to the US market average ratio of 17.32x. … But, to properly examine the value of a high-growth stock such as Nu Skin Enterprises, we must reflect its earnings growth into the valuation. … A PE ratio of 18.08x and expected year-on-year earnings growth of 10% give Nu Skin Enterprises a higher PEG ratio of 1.74x.

Simply Wall St -

Nu Skin Enterprises, Inc. (NYSE:NUS) Is Yielding 3.7% - But Is It A Buy?

Nu Skin Enterprises has been paying dividends for a long time, but for the purpose of this analysis, we only examine the past 10 years of payments. … Conclusion To summarise, shareholders should always check that Nu Skin Enterprises's dividends are affordable, that its dividend payments are relatively stable, and that it has decent prospects for growing its earnings and dividend. … Nu Skin Enterprises's is paying out more than half its income as dividends, but at least the dividend is covered by both reported earnings and cashflow.

Simply Wall St -

Did You Manage To Avoid Nu Skin Enterprises's (NYSE:NUS) Painful 52% Share Price Drop?

We've already covered Nu Skin Enterprises's share price action, but we should also mention its total shareholder return (TSR). … Dividends have been really beneficial for Nu Skin Enterprises shareholders, and that cash payout explains why its total shareholder loss of 50%, over the last year, isn't as bad as the share price return. … A Different Perspective While the broader market gained around 1.2% in the last year, Nu Skin Enterprises shareholders lost 50% (even including dividends).

Simply Wall St -

With A Return On Equity Of 16%, Has Nu Skin Enterprises, Inc.'s (NYSE:NUS) Management Done Well?

The formula for ROE is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Nu Skin Enterprises: 16% = US$129m ÷ US$811m (Based on the trailing twelve months to March 2019.) Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. … Does Nu Skin Enterprises Have A Good Return On Equity? … Nu Skin Enterprises's Debt And Its 16% ROE While Nu Skin Enterprises does have some debt, with debt to equity of just 0.49, we wouldn't say debt is excessive.

Simply Wall St -

An Intrinsic Calculation For Nu Skin Enterprises, Inc. (NYSE:NUS) Suggests It's 31% Undervalued

Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars: 10-year free cash flow (FCF) estimate 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Levered FCF ($, Millions) $189.3m $188.1m $188.9m $190.9m $193.9m $197.7m $201.9m $206.7m $211.7m $217.1m Growth Rate Estimate Source Analyst x2 Est @ -0.62% Est @ 0.38% Est @ 1.09% Est @ 1.58% Est @ 1.92% Est @ 2.17% Est @ 2.34% Est @ 2.45% Est @ 2.54% Present Value ($, Millions) Discounted @ 8.27% $174.9 $160.5 $148.8 $138.9 $130.3 $122.7 $115.8 $109.4 $103.5 $98.1 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF)= $1.3b After calculating the present value of future cash flows in the intial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. … In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.3%. … NYSE:NUS Intrinsic value, July 18th 2019 Important assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows.

Simply Wall St -

Why We Like Nu Skin Enterprises, Inc.’s (NYSE:NUS) 24% Return On Capital Employed

The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Nu Skin Enterprises: 0.24 = US$328m ÷ (US$1.8b - US$402m) (Based on the trailing twelve months to March 2019.) Therefore, Nu Skin Enterprises has an ROCE of 24%. … Do Nu Skin Enterprises's Current Liabilities Skew Its ROCE? … What We Can Learn From Nu Skin Enterprises's ROCE With low current liabilities and a high ROCE, Nu Skin Enterprises could be worthy of further investigation.

Simply Wall St -

Can We See Significant Institutional Ownership On The Nu Skin Enterprises, Inc. (NYSE:NUS) Share Register?

See our latest analysis for Nu Skin Enterprises NYSE:NUS Ownership Summary, June 14th 2019 What Does The Institutional Ownership Tell Us About Nu Skin Enterprises? … We can see that Nu Skin Enterprises does have institutional investors; and they hold 80% of the stock. … Insider Ownership Of Nu Skin Enterprises While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders.

Simply Wall St -

Does Nu Skin Enterprises, Inc.'s (NYSE:NUS) June Stock Price Reflect Its Future Growth?

Nu Skin Enterprises is available at price-to-earnings ratio of 20.04x, showing us it is undervalued based on its latest annual earnings update compared to the Personal Products average of 20.04x , and overvalued compared to the US market average ratio of 17.03x. … NYSE:NUS Price Estimation Relative to Market, June 3rd 2019 Nu Skin Enterprises's price-to-earnings ratio stands at 20.04x, which is low, relative to the industry average. … A PE ratio of 20.04x and expected year-on-year earnings growth of 15% give Nu Skin Enterprises a higher PEG ratio of 1.31x.

Simply Wall St -

Do You Know What Nu Skin Enterprises, Inc.'s (NYSE:NUS) P/E Ratio Means?

We'll look at Nu Skin Enterprises, Inc.'s (NYSE:NUS) P/E ratio and reflect on what it tells us about the company's share price. … The formula for P/E is: Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS) Or for Nu Skin Enterprises: P/E of 22.95 = $53.46 ÷ $2.33 (Based on the year to March 2019.) Is A High Price-to-Earnings Ratio Good? … Nu Skin Enterprises shrunk earnings per share by 10.0% last year.

Simply Wall St -

Is Nu Skin Enterprises, Inc.'s (NYSE:NUS) Balance Sheet Strong Enough To Weather A Storm?

Help shape the future of investing tools and you could win a $250 gift card! … (NYSE:NUS) with its market cap of US$3.1b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

NUS Company Info

Description

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Details
Name: Nu Skin Enterprises, Inc.
NUS
Exchange: NYSE
Founded: 1984
$1,225,371,540
55,547,214
Website: http://www.nuskin.com
Address: Nu Skin Enterprises, Inc.
75 West Center Street,
Provo,
Utah, 84601,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE NUS Class A Common Stock New York Stock Exchange US USD 22. Nov 1996
DB NUS Class A Common Stock Deutsche Boerse AG DE EUR 22. Nov 1996
SWX NUS Class A Common Stock SIX Swiss Exchange CH CHF 22. Nov 1996
Number of employees
Current staff
Staff numbers
4,900
Nu Skin Enterprises employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/05 03:23
End of day share price update: 2020/04/03 00:00
Last estimates confirmation: 2020/03/20
Last earnings filing: 2020/02/13
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.